Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1995 2
1996 3
1997 3
1999 5
2000 4
2001 2
2002 3
2003 3
2004 3
2005 7
2006 9
2007 3
2008 5
2009 7
2010 2
2011 1
2012 7
2013 5
2014 5
2015 5
2016 6
2017 3
2018 10
2019 7
2020 9
2021 7
2022 8
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.
Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, D'Alessio DA, Haupt A. Coskun T, et al. Among authors: gimeno re. Mol Metab. 2018 Dec;18:3-14. doi: 10.1016/j.molmet.2018.09.009. Epub 2018 Oct 3. Mol Metab. 2018. PMID: 30473097 Free PMC article. Clinical Trial.
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.
Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, O'Farrell LS, Briere DA, Sloop KW, Thomas MK, Pirro V, Wainscott DB, Willard FS, Abernathy M, Morford L, Du Y, Benson C, Gimeno RE, Haupt A, Milicevic Z. Coskun T, et al. Among authors: gimeno re. Cell Metab. 2022 Sep 6;34(9):1234-1247.e9. doi: 10.1016/j.cmet.2022.07.013. Epub 2022 Aug 18. Cell Metab. 2022. PMID: 35985340 Free article.
GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice.
Samms RJ, Christe ME, Collins KA, Pirro V, Droz BA, Holland AK, Friedrich JL, Wojnicki S, Konkol DL, Cosgrove R, Furber EPC, Ruan X, O'Farrell LS, Long AM, Dogra M, Willency JA, Lin Y, Ding L, Cheng CC, Cabrera O, Briere DA, Alsina-Fernandez J, Gimeno RE, Moyers JS, Coskun T, Coghlan MP, Sloop KW, Roell WC. Samms RJ, et al. Among authors: gimeno re. J Clin Invest. 2021 Jun 15;131(12):e146353. doi: 10.1172/JCI146353. J Clin Invest. 2021. PMID: 34003802 Free PMC article.
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
Frias JP, Nauck MA, Van J, Kutner ME, Cui X, Benson C, Urva S, Gimeno RE, Milicevic Z, Robins D, Haupt A. Frias JP, et al. Among authors: gimeno re. Lancet. 2018 Nov 17;392(10160):2180-2193. doi: 10.1016/S0140-6736(18)32260-8. Epub 2018 Oct 4. Lancet. 2018. PMID: 30293770 Clinical Trial.
The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.
Emmerson PJ, Wang F, Du Y, Liu Q, Pickard RT, Gonciarz MD, Coskun T, Hamang MJ, Sindelar DK, Ballman KK, Foltz LA, Muppidi A, Alsina-Fernandez J, Barnard GC, Tang JX, Liu X, Mao X, Siegel R, Sloan JH, Mitchell PJ, Zhang BB, Gimeno RE, Shan B, Wu X. Emmerson PJ, et al. Among authors: gimeno re. Nat Med. 2017 Oct;23(10):1215-1219. doi: 10.1038/nm.4393. Epub 2017 Aug 28. Nat Med. 2017. PMID: 28846098
Leveraging the Gut to Treat Metabolic Disease.
Gimeno RE, Briere DA, Seeley RJ. Gimeno RE, et al. Cell Metab. 2020 Apr 7;31(4):679-698. doi: 10.1016/j.cmet.2020.02.014. Epub 2020 Mar 17. Cell Metab. 2020. PMID: 32187525 Free PMC article. Review.
Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice.
Galindo-Campos MA, Lutfi N, Bonnin S, Martínez C, Velasco-Hernandez T, García-Hernández V, Martín-Caballero J, Ampurdanés C, Gimeno R, Colomo L, Roué G, Guilbaud G, Dantzer F, Navarro P, Murga M, Fernández-Capetillo O, Bigas A, Menéndez P, Sale JE, Yélamos J. Galindo-Campos MA, et al. Among authors: gimeno r. Blood. 2022 Jan 13;139(2):228-239. doi: 10.1182/blood.2021012805. Blood. 2022. PMID: 34359075 Free article.
COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing.
Grau S, Martín-García E, Ferrández O, Martín R, Tejedor-Vaquero S, Gimeno R, Magri G, Maldonado R. Grau S, et al. Among authors: gimeno r. Vaccines (Basel). 2022 Apr 12;10(4):594. doi: 10.3390/vaccines10040594. Vaccines (Basel). 2022. PMID: 35455343 Free PMC article.
Fatty acid transport proteins.
Gimeno RE. Gimeno RE. Curr Opin Lipidol. 2007 Jun;18(3):271-6. doi: 10.1097/MOL.0b013e3281338558. Curr Opin Lipidol. 2007. PMID: 17495600 Review.
127 results